Clinical Trial Update: Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in the Asia Pacific region comparing etanercept with usual DMARD therapy for rheumatoid arthritis has completed, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2010-08-30